Lampertico, P., Berg, T., Buti, M., Pathil, A., Petersen, J., Ryder, S. D., . . . Larrey, D. (2020). Treatment with tenofovir disoproxil fumarate or entecavir in chronic hepatitis B virus‐infected patients with renal impairment: Results from a 7‐year, multicentre retrospective cohort study. Alimentary Pharmacology & Therapeutics, 52(3), 500. https://doi.org/10.1111/apt.15901
Chicago Style (17th ed.) CitationLampertico, Pietro, et al. "Treatment with Tenofovir Disoproxil Fumarate or Entecavir in Chronic Hepatitis B Virus‐infected Patients with Renal Impairment: Results from a 7‐year, Multicentre Retrospective Cohort Study." Alimentary Pharmacology & Therapeutics 52, no. 3 (2020): 500. https://doi.org/10.1111/apt.15901.
MLA (9th ed.) CitationLampertico, Pietro, et al. "Treatment with Tenofovir Disoproxil Fumarate or Entecavir in Chronic Hepatitis B Virus‐infected Patients with Renal Impairment: Results from a 7‐year, Multicentre Retrospective Cohort Study." Alimentary Pharmacology & Therapeutics, vol. 52, no. 3, 2020, p. 500, https://doi.org/10.1111/apt.15901.